Cargando…

Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report

We present a case where we evaluated the effectiveness of nebulized fentanyl in the treatment of refractive dyspnea in a patient with chronic obstructive pulmonary disease (COPD) with major complications and comorbidities. Nebulized fentanyl was used to successfully decrease the subjective symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hildreth, Leah, Pett, Danielle, Higgins, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596332/ https://www.ncbi.nlm.nih.gov/pubmed/33145156 http://dx.doi.org/10.1016/j.rmcr.2020.101251

Ejemplares similares

Palliative management of refractory dyspnea in COPD
por: Uronis, Hope E, et al.
Publicado: (2006)

Clinical evaluation of nebulized verapamil in out‐patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease
por: Fahimi, Fanak, et al.
Publicado: (2022)

Effect of Nebulized Verapamil on Oxygenation in Chronic Obstructive Pulmonary Disease (COPD) Patients Admitted to the Intensive Care Unit
por: Pourdowlat, Guitti, et al.
Publicado: (2019)

Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease
por: Santus, Pierachille, et al.
Publicado: (2017)

Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD)
por: van Dijk, Marlies, et al.
Publicado: (2021)

Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease
por: Chhabra, S. K., et al.
Publicado: (2009)

Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Vozoris, Nicholas T.
Publicado: (2021)

Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease
por: Leaker, Brian R, et al.
Publicado: (2015)

Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease
por: de Torres, Juan P, et al.
Publicado: (2007)

Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhang, Rui, et al.
Publicado: (2020)

The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home
por: Talwar, Deepak, et al.
Publicado: (2021)

Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial)
por: Shaikh, Nissar, et al.
Publicado: (2022)

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease
por: Perez, Thierry, et al.
Publicado: (2015)

Exercise dyspnea in patients with COPD
por: Stendardi, Loredana, et al.
Publicado: (2007)

Predictors of Morphine Efficacy for Dyspnea in Inpatients with Chronic Obstructive Pulmonary Disease: A Secondary Analysis of JORTC-PAL 07
por: Matsuda, Yoshinobu, et al.
Publicado: (2021)

Is nebulized saline a placebo in COPD?
por: Khan, Shahina Y, et al.
Publicado: (2004)

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
por: Ganapathy, Vaidyanathan, et al.
Publicado: (2017)

Future Trends in Nebulized Therapies for Pulmonary Disease
por: McCarthy, Sean D., et al.
Publicado: (2020)

Brain Activation during Perception and Anticipation of Dyspnea in Chronic Obstructive Pulmonary Disease
por: Esser, Roland W., et al.
Publicado: (2017)

Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Mammen, Manoj J., et al.
Publicado: (2021)

Modeling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency department
por: Gueho, Florian, et al.
Publicado: (2016)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

A review of nebulized drug delivery in COPD
por: Tashkin, Donald P
Publicado: (2016)

Effectiveness of treatment with nebulized colistin in patients with COPD
por: Bruguera-Avila, Nuria, et al.
Publicado: (2017)

Nebulized Therapies in COPD: Past, Present, and the Future
por: Barjaktarevic, Igor Z, et al.
Publicado: (2020)

Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study
por: Oga, Toru, et al.
Publicado: (2012)

Anthropometric Indicators Associated with Dyspnea and Spirometric Parameters in Patients with Chronic Obstructive Pulmonary Disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2016)

Scale of dyspnea in COPD: User friendly?
por: Wiwanitkit, Viroj
Publicado: (2010)

Brain Activations to Dyspnea in Patients With COPD
por: Reijnders, Thomas, et al.
Publicado: (2020)

Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients
por: Castro, Antonio A.M., et al.
Publicado: (2012)

An atlas of chronic obstructive pulmonary disease, COPD
por: Hansel, T. T. (Trevor T.), 1956-
Publicado: (2004)

Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β(2)-Agonists
por: Bollu, Vamsi, et al.
Publicado: (2016)

Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
por: Liu, Chia-Ying, et al.
Publicado: (2011)

Effect of Self-Management Program on Health Status and Dyspnea in Patients with Chronic Obstructive Pulmonary Disease
por: Hasanpour Dehkordi, Ali, et al.
Publicado: (2022)

The minimal important difference of the pulmonary functional status and dyspnea questionnaire in patients with severe chronic obstructive pulmonary disease
por: Regueiro, Eloisa MG, et al.
Publicado: (2013)

Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD
por: Siler, Thomas M., et al.
Publicado: (2021)

Effects of inhaled furosemide on dyspnea and pulmonary function in people with COPD: A literature review
por: Atwi, Zeina
Publicado: (2022)

Evaluation effects of nebulized gentamicin in exacerbation of chronic obstructive lung disease
por: Soltaninejad, Forogh, et al.
Publicado: (2016)

Evaluation of Quality of Life with the Chronic Obstructive Pulmonary Disease Assessment Test in Chronic Obstructive Pulmonary Disease and the Effect of Dyspnea on Disease-Specific Quality of Life in These Patients
por: Okutan, Oguzhan, et al.
Publicado: (2013)

Chronic Obstructive Pulmonary Disease (COPD) is associated with pulmonary artery stiffness - the MESA COPD study
por: Liu, Chia-Ying, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4usqumvere5m2bt0dp5u21t2da